Development of optical biosensor technologies for cardiac troponin recognition

Area of Science:

• Biomedical Engineering
• Cardiovascular Medicine
• Analytical Chemistry

Background:

• Acute myocardial infarction (AMI) remains a primary cause of cardiovascular mortality.
• Cardiac troponin is a specific and sensitive biomarker for diagnosing AMI.
• Elevated cardiac troponin levels persist for 4-10 days post-AMI, enabling a prolonged diagnostic window.

Purpose of the Study:

• To review optical immunosensing methods for cardiac troponin detection.
• To provide an overview of diagnostic cardiac troponin immunosensors used in recent years.
• To highlight the importance of sensitive detection methods for cardiac troponin.

Main Methods:

• Focus on optical detection techniques for cardiac troponin.
• Discussion of various optical immunosensing strategies.
• Review of recently developed cardiac troponin immunosensors.

Main Results:

• Optical immunosensing offers high sensitivity for detecting low cardiac troponin concentrations.
• Various optical methods have been successfully employed for cardiac troponin determination.
• The long detection window of cardiac troponin is advantageous for AMI diagnosis.

Conclusions:

• Optical immunosensing presents a promising approach for sensitive and timely detection of cardiac troponin.
• Advancements in immunosensor technology are crucial for improving AMI diagnostics.
• Further research in optical detection methods can enhance cardiovascular disease management.